Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
HealthcareAdd-on
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
5CP-backed Radon has acquired Majestic Medical Solutions in a healthcare add-on transaction. The deal is described as enabling Majestic to scale its geographic footprint and broaden its capabilities.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026